Saratoga Investment (SAR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2024 annual meeting is scheduled for September 26, 2024, at 10:00 a.m. ET in New York, with shareholders of record as of July 29, 2024, eligible to vote.
The main business is the election of Christian L. Oberbeck as director for a term ending at the 2027 annual meeting.
Proxy materials and the annual report are available online, and shareholders are encouraged to vote by internet, phone, or mail.
Voting matters and shareholder proposals
Only one proposal is up for vote: the election of Christian L. Oberbeck as director.
The board unanimously recommends voting FOR the nominee.
Shareholders may submit proposals for the 2025 meeting by April 3, 2025, following specific bylaw requirements.
Board of directors and corporate governance
The board consists of five members, with a majority being independent as required by NYSE and the 1940 Act.
Directors are divided into three classes, each serving three-year terms.
Annual board and committee effectiveness evaluations are conducted.
All directors attended 100% of meetings in fiscal 2024.
Corporate governance documents and codes of ethics are available online.
Latest events from Saratoga Investment
- Adjusted NII per share up 12% to $1.05, with strong liquidity and high portfolio quality.SAR
Q1 20253 Feb 2026 - NII, NAV, and dividend per share rose, with all watchlist investments resolved and strong liquidity.SAR
Q2 202519 Jan 2026 - Adjusted NII $12.4M, 9.2% LTM ROE, strong portfolio quality, and special dividend paid.SAR
Q3 202510 Jan 2026 - NAV and NII per share up sequentially; portfolio quality and liquidity remain strong.SAR
Q3 20268 Jan 2026 - Stockholders will vote on director elections and auditor ratification, with strong board oversight.SAR
Proxy Filing1 Dec 2025 - NAV up 6.1% to $392.7M, monthly dividends initiated, portfolio quality remains strong.SAR
Q4 202520 Nov 2025 - Adjusted NII per share up 17.9%, strong ROE, high credit quality, and robust liquidity.SAR
Q1 202616 Nov 2025 - NAV up, ROE strong, NII down; portfolio resilient with low non-accruals and high liquidity.SAR
Q2 20268 Oct 2025